Insight or Confusion: Survival After Response-Guided Neoadjuvant Chemotherapy in Breast Cancer

被引：7
|
作者：
Telli, Melinda L. [1 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 29期
关键词：
III RANDOMIZED GEPARTRIO; PREOPERATIVE CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; TRASTUZUMAB; THERAPY; TRIAL; CYCLOPHOSPHAMIDE; PACLITAXEL; EPIRUBICIN;
D O I：
10.1200/JCO.2013.51.0313
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3613 / 3615
页数：3
相关论文
共 50 条
  • [1] Response-Guided Neoadjuvant Chemotherapy for Breast Cancer
    von Minckwitz, Gunter
    Blohmer, Jens Uwe
    Costa, Serban Dan
    Denkert, Carsten
    Eidtmann, Holger
    Eiermann, Wolfgang
    Gerber, Bernd
    Hanusch, Claus
    Hilfrich, Joern
    Huober, Jens
    Jackisch, Christian
    Kaufmann, Manfred
    Kuemmel, Sherko
    Paepke, Stefan
    Schneeweiss, Andreas
    Untch, Michael
    Zahm, Dirk Michael
    Mehta, Keyur
    Loibl, Sibylle
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (29) : 3623 - +
  • [2] Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients
    Miquel-Cases, Anna
    Retel, Valesca P.
    Lederer, Bianca
    von Minckwitz, Gunter
    Steuten, Lotte M. G.
    van Harten, Wim H.
    PLOS ONE, 2016, 11 (04):
  • [3] In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
    Ladoire, Sylvain
    Mignot, Gregoire
    Dabakuyo, Sandrine
    Arnould, Laurent
    Apetoh, Lionel
    Rebe, Cedric
    Coudert, Bruno
    Martin, Francois
    Bizollon, Marie Helene
    Vanoli, Andre
    Coutant, Charles
    Fumoleau, Pierre
    Bonnetain, Franck
    Ghiringhelli, Francois
    JOURNAL OF PATHOLOGY, 2011, 224 (03): : 389 - 400
  • [4] In Situ Immune Response after Neoadjuvant Chemotherapy for Breast Cancer Predicts Survival
    Ladoire, S.
    Coudert, B.
    Fumoleau, P.
    Arnould, L.
    Ghiringhelli, F.
    CANCER RESEARCH, 2010, 70
  • [5] CLINICAL AND PATHOLOGIC TUMOR RESPONSE FOLLOWING RESPONSE-GUIDED NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED BREAST CANCER IN THE PHILIPPINE GENERAL HOSPITAL - BREAST CARE CENTER
    Rapacon, R. L.
    Macalindong, S.
    BREAST, 2020, 50 : 158 - 158
  • [6] Development of breast cancer therapy: biomarker-driven and response-guided approaches in a neoadjuvant setting
    Toi, Masakazu
    Masuda, Norikazu
    Ishiguro, Hiroshi
    Saji, Shigehira
    Ohno, Shinji
    Chow, Louis W. C.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2015, 30 (02): : E252 - E253
  • [7] Predictive biomarkers of survival after neoadjuvant chemotherapy for breast cancer
    Galvez-Nino, Marco
    Roque, Katia
    Angel Bernabe, Luis
    Castillo, Miluska
    Sanchez, Joselyn
    Landa Baella, Maria
    Calderon, Gabriela
    De la Cruz, Miguel
    Dunstan, Jorge
    Abugatas, Julio
    Cotrina, Jose
    Castaneda, Carlos
    Gomez, Henry
    CANCER RESEARCH, 2020, 80 (04)
  • [8] Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer
    Woo, Jinsun
    Ryu, Jai Min
    Jung, Sung Mi
    Choi, Hee Jun
    Lee, Se Kyung
    Yu, Jonghan
    Lee, Jeong Eon
    Kim, Seok Won
    Nam, Seok Jin
    Chae, Byung Joo
    EJSO, 2021, 47 (02): : 232 - 239
  • [9] Survival and recurrence of breast cancer patients with pathologic complete response after neoadjuvant chemotherapy.
    Lee, Young Joo
    Ahn, Sei-Hyun
    Sohn, Byung Ho
    Lee, Jong Won
    Chung, Il Yong
    Ko, Beom Seok
    Kim, Hee Jeong
    Kim, Jisun
    Lee, Sae Byul
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer:: the role of clinical response
    Pierga, JY
    Mouret, E
    Laurence, V
    Diéras, V
    Savigioni, A
    Beuzeboc, P
    Dorval, T
    Palangié, T
    Jouve, M
    Pouillart, P
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (08) : 1089 - 1096
12345